Close Menu
Home » SIB, Quartz Bio to Improve MegaClust's Flow Cytometry Analysis Capabilities for Pharma

SIB, Quartz Bio to Improve MegaClust's Flow Cytometry Analysis Capabilities for Pharma

Feb 15, 2013
|
Uduak Grace Thomas
Premium

Quartz Bio and the Swiss Institute of Bioinformatics are working together to develop and validate MegaClust, SIB's platform for analyzing flow cytomery data, so that they can use it to provide analysis services to pharmaceutical companies.

The partners want to test whether or not MegaClust, which is comprised of a set of clustering algorithms, can be used to "systematically" assess large quantities of data generated from flow cytometry experiments in clinical trials, Jérôme Wojcik, Quartz Bio's CEO, told BioInform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Harvard Prof Charged

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

But What About That Preserved Frog Smell?

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Level of Transparency

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

PNAS Papers Describe Amish De Novo Mutation Decrease, RNA Sequencing Method, Precision Med Results

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

What's Popular?

In Informatics

  1. Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

    Premium

  2. Precision Health Company ixLayer Introduces Platform to Streamline Genetic Test Delivery

    Premium

  3. Noscendo, University Hospital Bonn Partner on Pathogen-Detection Platform Development

  4. Predictive Oncology to Acquire Quantitative Medicine

  5. Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.